Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-464 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
filingDate |
2003-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2005-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2005532825-A |
titleOfInvention |
Humanized antibodies against Venezuelan equine encephalitis virus |
abstract |
Humanized anti-VEEV antibodies can be used to protect and / or neutralize viral infection. Provided by the present invention is a humanized antibody that binds to an epitope on the envelope glycoprotein of Venezuelan equine encephalitis virus, the humanized antibody comprising at least one complementarity determining region derived from a non-human antibody and human A humanized antibody comprising at least one framework region derived from an antibody. A humanized antibody that binds to the E2 c epitope of Venezuelan equine encephalitis major glycoprotein E2 viruses, the humanized antibody comprises at least a CDR3 and derived from a human antibody derived from a murine antibody produced by the hybridoma cell 3B4C-4 1 Also provided are humanized antibodies comprising one framework region. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7214696-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022059283-A |
priorityDate |
2002-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |